{"schema_version":"secwatch.filing_event.v1","accession":"0001737287-23-000003","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2023-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.355582+00:00","generated_at":"2026-06-20T20:57:13.729945+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Allogene Therapeutics EVP of R&D Rafael Amado resigns effective Dec 30, 2022","bullets":["Rafael G. Amado, Executive Vice President of Research and Development, resigned.","Effective date of resignation: December 30, 2022.","Resignation is to pursue another opportunity; no replacement named.","Departure of top R&D executive may impact pipeline development."],"urls":{"canonical":"https://secwatch.observer/filing/0001737287-23-000003","json":"https://secwatch.observer/filing/0001737287-23-000003.json","markdown":"https://secwatch.observer/filing/0001737287-23-000003.md","text":"https://secwatch.observer/filing/0001737287-23-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000003/0001737287-23-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000003/allo-20221227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:57:13.729945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1820dfded4","claim":"Rafael G. Amado resigned as Executive Vice President of Research and Development at Allogene Therapeutics, Inc..","evidence_excerpt":"On December 27, 2022, Rafael G. Amado, M.D., the Executive Vice President of Research and Development of Allogene Therapeutics, Inc. (the “Company”), notified the Company of his decision to resign, effective December 30, 2022, to pursue another opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000003/0001737287-23-000003-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President of Research and Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}